Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Cecha
Wide-set eyes
Nazwa kliniczna: Hypertelorism
Interpupillary distance more than 2 SD above the mean (alternatively, the appearance of an increased interpupillary distance or widely spaced eyes).
Podsumowanie
- Znana także jako
- Widely spaced eyes, Excessive orbital separation, Increased distance between eye sockets, Increased distance between eyes, Increased interpupillary distance, Ocular hypertelorism, Widened interpupillary distance
- Układ organizmu
- Abnormality of the eye
Wide-set eyesHP:0000316
Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Read the genes linked to Wide-set eyes, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test886 genów powiązanych z Wide-set eyes
Zmiany w tych genach powodują rzadkie choroby, w których występuje Wide-set eyes. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Zawsze | W 2 chorobach |
| ADKadenosine kinase | Zawsze | W 1 chorobie |
| AIFM1apoptosis inducing factor mitochondria associated 1 | Zawsze | W 1 chorobie |
| ALDH6A1aldehyde dehydrogenase 6 family member A1 | Zawsze | W 1 chorobie |
| ALG1ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | Zawsze | W 1 chorobie |
| ALG13ALG13 UDP-N-acetylglucosaminyltransferase subunit | Zawsze | W 2 chorobach |
| ALX1ALX homeobox 1 | Zawsze | W 2 chorobach |
| ALX4ALX homeobox 4 | Zawsze | W 3 chorobach |
| AMOTL1angiomotin like 1 | Zawsze | W 1 chorobie |
| ANKHANKH inorganic pyrophosphate transport regulator | Zawsze | W 2 chorobach |
| ANTXR1ANTXR cell adhesion molecule 1 | Zawsze | W 2 chorobach |
| ARID2AT-rich interaction domain 2 | Zawsze | W 1 chorobie |
| ASXL2ASXL transcriptional regulator 2 | Zawsze | W 1 chorobie |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Zawsze | W 3 chorobach |
| ATRXATRX chromatin remodeler | Zawsze | W 3 chorobach |
| AXIN1axin 1 | Zawsze | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Zawsze | W 2 chorobach |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Zawsze | W 7 chorobach |
| BRD4bromodomain containing 4 | Zawsze | W 1 chorobie |
| CCBE1collagen and calcium binding EGF domains 1 | Zawsze | W 2 chorobach |
| CCDC22CCC complex scaffolding subunit CCDC22 | Zawsze | W 2 chorobach |
| CCNKcyclin K | Zawsze | W 1 chorobie |
| CDH1cadherin 1 | Zawsze | W 2 chorobach |
| CDH11cadherin 11 | Zawsze | W 3 chorobach |
| CHASERRCHD2 adjacent suppressive regulatory RNA | Zawsze | W 1 chorobie |
| CHST14carbohydrate sulfotransferase 14 | Zawsze | W 2 chorobach |
| COLEC11collectin subfamily member 11 | Zawsze | W 2 chorobach |
| CPAPcentrosome assembly and centriole elongation protein | Zawsze | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Zawsze | W 3 chorobach |
| DAND5DAN domain BMP antagonist family member 5 | Zawsze | W 1 chorobie |
| DDX59DEAD-box helicase 59 | Zawsze | W 2 chorobach |
| DHCR77-dehydrocholesterol reductase | Zawsze | W 2 chorobach |
| DHX9DExH-box helicase 9 | Zawsze | W 1 chorobie |
| DICER1dicer 1, ribonuclease III | Zawsze | W 1 chorobie |
| DMRT2doublesex and mab-3 related transcription factor 2 | Zawsze | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Zawsze | W 2 chorobach |
| DPH1diphthamide biosynthesis 1 | Zawsze | W 2 chorobach |
| EEDembryonic ectoderm development | Zawsze | W 1 chorobie |
| EFNB1ephrin B1 | Zawsze | W 2 chorobach |
| ELFN1extracellular leucine rich repeat and fibronectin type III domain containing 1 | Zawsze | W 1 chorobie |
Pokaż jeszcze 846 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| EP300EP300 lysine acetyltransferase | Zawsze | W 2 chorobach |
| ERFETS2 repressor factor | Zawsze | W 2 chorobach |
| FAT4FAT atypical cadherin 4 | Zawsze | W 4 chorobach |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Zawsze | W 2 chorobach |
| FGFR2fibroblast growth factor receptor 2 | Zawsze | W 17 chorobach |
| FILIP1filamin A interacting protein 1 | Zawsze | W 1 chorobie |
| FLNAfilamin A | Zawsze | W 13 chorobach |
| FLNBfilamin B | Zawsze | W 5 chorobach |
| FOXE1forkhead box E1 | Zawsze | W 1 chorobie |
| FUCA1alpha-L-fucosidase 1 | Zawsze | W 1 chorobie |
| FZD2frizzled class receptor 2 | Zawsze | W 3 chorobach |
| GJA1gap junction protein alpha 1 | Zawsze | W 3 chorobach |
| GNSglucosamine (N-acetyl)-6-sulfatase | Zawsze | W 1 chorobie |
| GPC4glypican 4 | Zawsze | W 3 chorobach |
| GTF3C3general transcription factor IIIC subunit 3 | Zawsze | W 1 chorobie |
| H4C11H4 clustered histone 11 | Zawsze | W 1 chorobie |
| HERC1HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 | Zawsze | W 2 chorobach |
| HIVEP2HIVEP zinc finger 2 | Zawsze | W 1 chorobie |
| HYAL2hyaluronidase 2 | Zawsze | W 1 chorobie |
| IDUAalpha-L-iduronidase | Zawsze | W 1 chorobie |
| IFT140intraflagellar transport 140 | Zawsze | W 1 chorobie |
| IL6STinterleukin 6 cytokine family signal transducer | Zawsze | W 1 chorobie |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Zawsze | W 1 chorobie |
| INTS11integrator complex subunit 11 | Zawsze | W 1 chorobie |
| IRX5iroquois homeobox 5 | Zawsze | W 1 chorobie |
| ITCHitchy E3 ubiquitin protein ligase | Zawsze | W 1 chorobie |
| JAG1jagged canonical Notch ligand 1 | Zawsze | W 1 chorobie |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Zawsze | W 2 chorobach |
| KCNK3potassium two pore domain channel subfamily K member 3 | Zawsze | W 1 chorobie |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| KIAA0753KIAA0753 | Zawsze | W 2 chorobach |
| KIF7kinesin family member 7 | Zawsze | W 5 chorobach |
| KRASKRas proto-oncogene, GTPase | Zawsze | W 4 chorobach |
| LBRlamin B receptor | Zawsze | W 2 chorobach |
| LTBP4latent transforming growth factor beta binding protein 4 | Zawsze | W 1 chorobie |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Zawsze | W 1 chorobie |
| MAN2B2mannosidase alpha class 2B member 2 | Zawsze | W 1 chorobie |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Zawsze | W 3 chorobach |
| MARS1methionyl-tRNA synthetase 1 | Zawsze | W 1 chorobie |
| MICU1mitochondrial calcium uptake 1 | Zawsze | W 1 chorobie |
| MOCS3molybdenum cofactor synthesis 3 | Zawsze | W 1 chorobie |
| MRASmuscle RAS oncogene homolog | Zawsze | W 2 chorobach |
| MRPS14mitochondrial ribosomal protein S14 | Zawsze | W 1 chorobie |
| MSL2MSL complex subunit 2 | Zawsze | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Zawsze | W 2 chorobach |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Zawsze | W 1 chorobie |
| MYH3myosin heavy chain 3 | Zawsze | W 3 chorobach |
| NAA80N-alpha-acetyltransferase 80, NatH catalytic subunit | Zawsze | W 1 chorobie |
| NBNnibrin | Zawsze | W 1 chorobie |
| NFASCneurofascin | Zawsze | W 1 chorobie |
| NOTCH2notch receptor 2 | Zawsze | W 2 chorobach |
| NRASNRAS proto-oncogene, GTPase | Zawsze | W 3 chorobach |
| NSD1nuclear receptor binding SET domain protein 1 | Zawsze | W 3 chorobach |
| NXNnucleoredoxin | Zawsze | W 2 chorobach |
| ODC1ornithine decarboxylase 1 | Zawsze | W 2 chorobach |
| OGTO-linked N-acetylglucosamine (GlcNAc) transferase | Zawsze | W 1 chorobie |
| PALB2partner and localizer of BRCA2 | Zawsze | W 2 chorobach |
| PDZD8PDZ domain containing 8 | Zawsze | W 1 chorobie |
| PEPDpeptidase D | Zawsze | W 2 chorobach |
| PEX1peroxisomal biogenesis factor 1 | Zawsze | W 1 chorobie |
| PEX6peroxisomal biogenesis factor 6 | Zawsze | W 2 chorobach |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Zawsze | W 2 chorobach |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Zawsze | W 1 chorobie |
| PIGBphosphatidylinositol glycan anchor biosynthesis class B | Zawsze | W 2 chorobach |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Zawsze | W 2 chorobach |
| PLCB3phospholipase C beta 3 | Zawsze | W 1 chorobie |
| POC1APOC1 centriolar protein A | Zawsze | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Zawsze | W 2 chorobach |
| PTH1Rparathyroid hormone 1 receptor | Zawsze | W 3 chorobach |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Zawsze | W 4 chorobach |
| PTRH2peptidyl-tRNA hydrolase 2 | Zawsze | W 2 chorobach |
| PUM1pumilio RNA binding family member 1 | Zawsze | W 1 chorobie |
| PYCR1pyrroline-5-carboxylate reductase 1 | Zawsze | W 2 chorobach |
| RAC3Rac family small GTPase 3 | Zawsze | W 1 chorobie |
| RAP1GDS1Rap1 GTPase-GDP dissociation stimulator 1 | Zawsze | W 1 chorobie |
| RAPSNreceptor associated protein of the synapse | Zawsze | W 2 chorobach |
| RECQL4RecQ like helicase 4 | Zawsze | W 3 chorobach |
| RIPK4receptor interacting serine/threonine kinase 4 | Zawsze | W 2 chorobach |
| RNF2ring finger protein 2 | Zawsze | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Zawsze | W 3 chorobach |
| RSPRY1ring finger and SPRY domain containing 1 | Zawsze | W 2 chorobach |
| SEC23ASEC23 homolog A, COPII component | Zawsze | W 2 chorobach |
| SETD2SET domain containing 2, histone lysine methyltransferase | Zawsze | W 1 chorobie |
| SH3PXD2BSH3 and PX domains 2B | Zawsze | W 2 chorobach |
| SIAH1siah E3 ubiquitin protein ligase 1 | Zawsze | W 1 chorobie |
| SIK3SIK family kinase 3 | Zawsze | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Zawsze | W 2 chorobach |
| SKIC3SKI3 subunit of superkiller complex | Zawsze | W 2 chorobach |
| SLC37A4solute carrier family 37 member 4 | Zawsze | W 1 chorobie |
| SLC39A13solute carrier family 39 member 13 | Zawsze | W 1 chorobie |
| SNAP29synaptosome associated protein 29 | Zawsze | W 2 chorobach |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Zawsze | W 2 chorobach |
| STRADASTE20 related adaptor alpha | Zawsze | W 1 chorobie |
| SUFUSUFU negative regulator of hedgehog signaling | Zawsze | W 2 chorobach |
| SUPT7LSPT7 like, STAGA complex subunit gamma | Zawsze | W 1 chorobie |
| TASP1taspase 1 | Zawsze | W 1 chorobie |
| TBC1D32TBC1 domain family member 32 | Zawsze | W 2 chorobach |
| TBX15T-box transcription factor 15 | Zawsze | W 2 chorobach |
| TCF3transcription factor 3 | Zawsze | W 2 chorobach |
| TMCO1transmembrane and coiled-coil domains 1 | Zawsze | W 2 chorobach |
| TPRKBTP53RK binding protein | Zawsze | W 2 chorobach |
| TTC7Atetratricopeptide repeat domain 7A | Zawsze | W 1 chorobie |
| TWIST1twist family bHLH transcription factor 1 | Zawsze | W 5 chorobach |
| UBAP2Lubiquitin associated protein 2 like | Zawsze | W 1 chorobie |
| UBR5ubiquitin protein ligase E3 component n-recognin 5 | Zawsze | W 1 chorobie |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| UNC13Aunc-13 homolog A | Zawsze | W 1 chorobie |
| VPS35LVPS35 endosomal protein sorting factor like | Zawsze | W 2 chorobach |
| WDR35WD repeat domain 35 | Zawsze | W 1 chorobie |
| ZMPSTE24zinc metallopeptidase STE24 | Zawsze | W 2 chorobach |
| ZSWIM6zinc finger SWIM-type containing 6 | Zawsze | W 2 chorobach |
| ACTBactin beta | Bardzo często (80–99%) | W 3 chorobach |
| ACTG1actin gamma 1 | Bardzo często (80–99%) | W 2 chorobach |
| AGAaspartylglucosaminidase | Bardzo często (80–99%) | W 1 chorobie |
| ANKRD11ankyrin repeat domain 11 | Bardzo często (80–99%) | W 2 chorobach |
| ATP6V1AATPase H+ transporting V1 subunit A | Bardzo często (80–99%) | W 2 chorobach |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Bardzo często (80–99%) | W 2 chorobach |
| B4GALT7beta-1,4-galactosyltransferase 7 | Bardzo często (80–99%) | W 1 chorobie |
| BMP2bone morphogenetic protein 2 | Bardzo często (80–99%) | W 1 chorobie |
| BRPF1bromodomain and PHD finger containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| CBLCbl proto-oncogene | Bardzo często (80–99%) | W 2 chorobach |
| CHST3carbohydrate sulfotransferase 3 | Bardzo często (80–99%) | W 3 chorobach |
| COL11A1collagen type XI alpha 1 chain | Bardzo często (80–99%) | W 3 chorobach |
| CPLX1complexin 1 | Bardzo często (80–99%) | W 3 chorobach |
| CTBP1C-terminal binding protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| DDR2discoidin domain receptor tyrosine kinase 2 | Bardzo często (80–99%) | W 1 chorobie |
| DPYSL5dihydropyrimidinase like 5 | Bardzo często (80–99%) | W 2 chorobach |
| DSEdermatan sulfate epimerase | Bardzo często (80–99%) | W 2 chorobach |
| DVL1dishevelled segment polarity protein 1 | Bardzo często (80–99%) | W 3 chorobach |
| DVL3dishevelled segment polarity protein 3 | Bardzo często (80–99%) | W 2 chorobach |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Bardzo często (80–99%) | W 2 chorobach |
| EHMT1euchromatic histone lysine methyltransferase 1 | Bardzo często (80–99%) | W 2 chorobach |
| ERMARDER membrane associated RNA degradation | Bardzo często (80–99%) | W 1 chorobie |
| ESCO2establishment of sister chromatid cohesion N-acetyltransferase 2 | Bardzo często (80–99%) | W 4 chorobach |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Bardzo często (80–99%) | W 2 chorobach |
| FBN1fibrillin 1 | Bardzo często (80–99%) | W 4 chorobach |
| FGF20fibroblast growth factor 20 | Bardzo często (80–99%) | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Bardzo często (80–99%) | W 7 chorobach |
| FREM1FRAS1 related extracellular matrix 1 | Bardzo często (80–99%) | W 3 chorobach |
| GFRA1GDNF family receptor alpha 1 | Bardzo często (80–99%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Bardzo często (80–99%) | W 1 chorobie |
| GLI3GLI family zinc finger 3 | Bardzo często (80–99%) | W 4 chorobach |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Bardzo często (80–99%) | W 2 chorobach |
| GPC3glypican 3 | Bardzo często (80–99%) | W 2 chorobach |
| GREB1LGREB1 like retinoic acid receptor coactivator | Bardzo często (80–99%) | W 1 chorobie |
| HDAC4histone deacetylase 4 | Bardzo często (80–99%) | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Bardzo często (80–99%) | W 1 chorobie |
| INTS1integrator complex subunit 1 | Bardzo często (80–99%) | W 1 chorobie |
| ITGA8integrin subunit alpha 8 | Bardzo często (80–99%) | W 2 chorobach |
| KATNB1katanin regulatory subunit B1 | Bardzo często (80–99%) | W 1 chorobie |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Bardzo często (80–99%) | W 3 chorobach |
| KCNMA1potassium calcium-activated channel subfamily M alpha 1 | Bardzo często (80–99%) | W 1 chorobie |
| LEMD3LEM domain containing 3 | Bardzo często (80–99%) | W 1 chorobie |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| LMNAlamin A/C | Bardzo często (80–99%) | W 1 chorobie |
| LRP2LDL receptor related protein 2 | Bardzo często (80–99%) | W 2 chorobach |
| LRP5LDL receptor related protein 5 | Bardzo często (80–99%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Bardzo często (80–99%) | W 3 chorobach |
| MAP2K2mitogen-activated protein kinase kinase 2 | Bardzo często (80–99%) | W 3 chorobach |
| MEGF8multiple EGF like domains 8 | Bardzo często (80–99%) | W 2 chorobach |
| MID1midline 1 | Bardzo często (80–99%) | W 2 chorobach |
| MN1MN1 proto-oncogene, transcriptional regulator | Bardzo często (80–99%) | W 1 chorobie |
| NALCNsodium leak channel, non-selective | Bardzo często (80–99%) | W 2 chorobach |
| NDE1nudE neurodevelopment protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| NELFAnegative elongation factor complex member A | Bardzo często (80–99%) | W 1 chorobie |
| NF1neurofibromin 1 | Bardzo często (80–99%) | W 6 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Bardzo często (80–99%) | W 3 chorobach |
| OFD1OFD1 centriole and centriolar satellite protein | Bardzo często (80–99%) | W 3 chorobach |
| PAFAH1B1platelet activating factor acetylhydrolase 1b regulatory subunit 1 | Bardzo często (80–99%) | W 1 chorobie |
| PAX3paired box 3 | Bardzo często (80–99%) | W 3 chorobach |
| PGAP2post-GPI attachment to proteins 2 | Bardzo często (80–99%) | W 2 chorobach |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Bardzo często (80–99%) | W 2 chorobach |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Bardzo często (80–99%) | W 3 chorobach |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Bardzo często (80–99%) | W 2 chorobach |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Bardzo często (80–99%) | W 1 chorobie |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Bardzo często (80–99%) | W 1 chorobie |
| POGZpogo transposable element derived with ZNF domain | Bardzo często (80–99%) | W 2 chorobach |
| POLR1ARNA polymerase I subunit A | Bardzo często (80–99%) | W 2 chorobach |
| POLR3ARNA polymerase III subunit A | Bardzo często (80–99%) | W 2 chorobach |
| RAB23RAB23, member RAS oncogene family | Bardzo często (80–99%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 4 chorobach |
| RASA2RAS p21 protein activator 2 | Bardzo często (80–99%) | W 1 chorobie |
| RB1RB transcriptional corepressor 1 | Bardzo często (80–99%) | W 1 chorobie |
| RELNreelin | Bardzo często (80–99%) | W 1 chorobie |
| RETret proto-oncogene | Bardzo często (80–99%) | W 1 chorobie |
| RIT1Ras like without CAAX 1 | Bardzo często (80–99%) | W 2 chorobach |
| ROR2ROR family WNT receptor 2 | Bardzo często (80–99%) | W 2 chorobach |
| RRASRAS related | Bardzo często (80–99%) | W 1 chorobie |
| RRAS2RAS related 2 | Bardzo często (80–99%) | W 1 chorobie |
| RUNX2RUNX family transcription factor 2 | Bardzo często (80–99%) | W 2 chorobach |
| RYR1ryanodine receptor 1 | Bardzo często (80–99%) | W 2 chorobach |
| SETD5SET domain containing 5 | Bardzo często (80–99%) | W 1 chorobie |
| SKISKI proto-oncogene | Bardzo często (80–99%) | W 2 chorobach |
| SLC25A24solute carrier family 25 member 24 | Bardzo często (80–99%) | W 2 chorobach |
| SLC29A3solute carrier family 29 member 3 | Bardzo często (80–99%) | W 1 chorobie |
| SMOsmoothened, frizzled class receptor | Bardzo często (80–99%) | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Bardzo często (80–99%) | W 2 chorobach |
| SOX9SRY-box transcription factor 9 | Bardzo często (80–99%) | W 2 chorobach |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Bardzo często (80–99%) | W 2 chorobach |
| SPOPspeckle type BTB/POZ protein | Bardzo często (80–99%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Bardzo często (80–99%) | W 2 chorobach |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Bardzo często (80–99%) | W 2 chorobach |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Bardzo często (80–99%) | W 1 chorobie |
| TCTN3tectonic family member 3 | Bardzo często (80–99%) | W 4 chorobach |
| TFAP2Btranscription factor AP-2 beta | Bardzo często (80–99%) | W 2 chorobach |
| TFE3transcription factor binding to IGHM enhancer 3 | Bardzo często (80–99%) | W 1 chorobie |
| TGFBR1transforming growth factor beta receptor 1 | Bardzo często (80–99%) | W 3 chorobach |
| TGFBR2transforming growth factor beta receptor 2 | Bardzo często (80–99%) | W 3 chorobach |
| TMEM53transmembrane protein 53 | Bardzo często (80–99%) | W 1 chorobie |
| TNFRSF11ATNF receptor superfamily member 11a | Bardzo często (80–99%) | W 1 chorobie |
| TOP2BDNA topoisomerase II beta | Bardzo często (80–99%) | W 1 chorobie |
| TRAPPC9trafficking protein particle complex subunit 9 | Bardzo często (80–99%) | W 2 chorobach |
| TWIST2twist family bHLH transcription factor 2 | Bardzo często (80–99%) | W 3 chorobach |
| TXNL4Athioredoxin like 4A | Bardzo często (80–99%) | W 2 chorobach |
| WASHC5WASH complex subunit 5 | Bardzo często (80–99%) | W 2 chorobach |
| WNT5AWnt family member 5A | Bardzo często (80–99%) | W 2 chorobach |
| WNT9BWnt family member 9B | Bardzo często (80–99%) | W 1 chorobie |
| XYLT2xylosyltransferase 2 | Bardzo często (80–99%) | W 1 chorobie |
| YWHAEtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | Bardzo często (80–99%) | W 1 chorobie |
| ZBTB18zinc finger and BTB domain containing 18 | Bardzo często (80–99%) | W 2 chorobach |
| ABCD4ATP binding cassette subfamily D member 4 | Często (30–79%) | W 1 chorobie |
| ACOX1acyl-CoA oxidase 1 | Często (30–79%) | W 2 chorobach |
| ACTL6Bactin like 6B | Często (30–79%) | W 1 chorobie |
| AFF4ALF transcription elongation factor 4 | Często (30–79%) | W 1 chorobie |
| AHDC1AT-hook DNA binding motif containing 1 | Często (30–79%) | W 2 chorobach |
| AKT1AKT serine/threonine kinase 1 | Często (30–79%) | W 1 chorobie |
| AKT3AKT serine/threonine kinase 3 | Często (30–79%) | W 1 chorobie |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Często (30–79%) | W 2 chorobach |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Często (30–79%) | W 3 chorobach |
| ALPK3alpha kinase 3 | Często (30–79%) | W 1 chorobie |
| ALX3ALX homeobox 3 | Często (30–79%) | W 2 chorobach |
| ANAPC7anaphase promoting complex subunit 7 | Często (30–79%) | W 1 chorobie |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Często (30–79%) | W 1 chorobie |
| APCAPC regulator of Wnt signaling pathway | Często (30–79%) | W 2 chorobach |
| ARID1BAT-rich interaction domain 1B | Często (30–79%) | W 2 chorobach |
| ASH1LASH1 like histone lysine methyltransferase | Często (30–79%) | W 1 chorobie |
| ASNSasparagine synthetase (glutamine-hydrolyzing) | Często (30–79%) | W 1 chorobie |
| ASXL1ASXL transcriptional regulator 1 | Często (30–79%) | W 2 chorobach |
| ATP6V1B2ATPase H+ transporting V1 subunit B2 | Często (30–79%) | W 2 chorobach |
| ATXN7L3ataxin 7 like 3 | Często (30–79%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Często (30–79%) | W 2 chorobach |
| B3GLCTbeta 3-glucosyltransferase | Często (30–79%) | W 2 chorobach |
| B9D1B9 domain containing 1 | Często (30–79%) | W 1 chorobie |
| B9D2B9 domain containing 2 | Często (30–79%) | W 1 chorobie |
| BCL11BBCL11 transcription factor B | Często (30–79%) | W 2 chorobach |
| BCORL1BCL6 corepressor like 1 | Często (30–79%) | W 1 chorobie |
| BGNbiglycan | Często (30–79%) | W 1 chorobie |
| BMPR1Abone morphogenetic protein receptor type 1A | Często (30–79%) | W 1 chorobie |
| BORCS8BLOC-1 related complex subunit 8 | Często (30–79%) | W 1 chorobie |
| BPTFbromodomain PHD finger transcription factor | Często (30–79%) | W 2 chorobach |
| BRCC3BRCA1/BRCA2-containing complex subunit 3 | Często (30–79%) | W 1 chorobie |
| CAMTA1calmodulin binding transcription activator 1 | Często (30–79%) | W 1 chorobie |
| CASKcalcium/calmodulin dependent serine protein kinase | Często (30–79%) | W 3 chorobach |
| CC2D2Acoiled-coil and C2 domain containing 2A | Często (30–79%) | W 1 chorobie |
| CCDC32coiled-coil domain containing 32 | Często (30–79%) | W 1 chorobie |
| CCDC47coiled-coil domain containing 47 | Często (30–79%) | W 1 chorobie |
| CCND2cyclin D2 | Często (30–79%) | W 1 chorobie |
| CDK13cyclin dependent kinase 13 | Często (30–79%) | W 1 chorobie |
| CDK19cyclin dependent kinase 19 | Często (30–79%) | W 1 chorobie |
| CEP120centrosomal protein 120 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 2 chorobach |
| CHD3chromodomain helicase DNA binding protein 3 | Często (30–79%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Często (30–79%) | W 2 chorobach |
| CHRNGcholinergic receptor nicotinic gamma subunit | Często (30–79%) | W 3 chorobach |
| CILK1ciliogenesis associated kinase 1 | Często (30–79%) | W 1 chorobie |
| CLCN6Cl-/H+ antiporter 6 | Często (30–79%) | W 1 chorobie |
| CLCN7Cl-/H+ antiporter 7 | Często (30–79%) | W 1 chorobie |
| COG1component of oligomeric golgi complex 1 | Często (30–79%) | W 2 chorobach |
| COL1A1collagen type I alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COL1A2collagen type I alpha 2 chain | Często (30–79%) | W 1 chorobie |
| COL2A1collagen type II alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COLEC10collectin subfamily member 10 | Często (30–79%) | W 2 chorobach |
| COX7Bcytochrome c oxidase subunit 7B | Często (30–79%) | W 1 chorobie |
| CPLANE1ciliogenesis and planar polarity effector complex subunit 1 | Często (30–79%) | W 2 chorobach |
| CSPP1centrosome and spindle pole associated protein 1 | Często (30–79%) | W 3 chorobach |
| CTNND1catenin delta 1 | Często (30–79%) | W 2 chorobach |
| CTNND2catenin delta 2 | Często (30–79%) | W 1 chorobie |
| DDX6DEAD-box helicase 6 | Często (30–79%) | W 1 chorobie |
| DEF6DEF6 guanine nucleotide exchange factor | Często (30–79%) | W 1 chorobie |
| DHRS3dehydrogenase/reductase 3 | Często (30–79%) | W 1 chorobie |
| DLX4distal-less homeobox 4 | Często (30–79%) | W 1 chorobie |
| DOK7docking protein 7 | Często (30–79%) | W 1 chorobie |
| DOT1LDOT1 like histone lysine methyltransferase | Często (30–79%) | W 1 chorobie |
| DPM1dolichyl-phosphate mannosyltransferase subunit 1, catalytic | Często (30–79%) | W 2 chorobach |
| EBPEBP cholestenol delta-isomerase | Często (30–79%) | W 2 chorobach |
| EPB41L1erythrocyte membrane protein band 4.1 like 1 | Często (30–79%) | W 1 chorobie |
| EXOC2exocyst complex component 2 | Często (30–79%) | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Często (30–79%) | W 2 chorobach |
| FAAP100FA core complex associated protein 100 | Często (30–79%) | W 2 chorobach |
| FAM111AFAM111 trypsin like peptidase A | Często (30–79%) | W 1 chorobie |
| FAM149B1family with sequence similarity 149 member B1 | Często (30–79%) | W 1 chorobie |
| FANCLFA complementation group L | Często (30–79%) | W 2 chorobach |
| FAR1fatty acyl-CoA reductase 1 | Często (30–79%) | W 2 chorobach |
| FBXO22F-box protein 22 | Często (30–79%) | W 1 chorobie |
| FBXO31F-box protein 31 | Często (30–79%) | W 1 chorobie |
| FGFR3fibroblast growth factor receptor 3 | Często (30–79%) | W 6 chorobach |
| FGFRL1fibroblast growth factor receptor like 1 | Często (30–79%) | W 1 chorobie |
| FHfumarate hydratase | Często (30–79%) | W 2 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Często (30–79%) | W 2 chorobach |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Często (30–79%) | W 1 chorobie |
| FOXC1forkhead box C1 | Często (30–79%) | W 2 chorobach |
| FOXP1forkhead box P1 | Często (30–79%) | W 2 chorobach |
| FRAS1Fraser extracellular matrix complex subunit 1 | Często (30–79%) | W 2 chorobach |
| FREM2FRAS1 related extracellular matrix 2 | Często (30–79%) | W 1 chorobie |
| GAD1glutamate decarboxylase 1 | Często (30–79%) | W 1 chorobie |
| GLDNgliomedin | Często (30–79%) | W 1 chorobie |
| GPAA1glycosylphosphatidylinositol anchor attachment 1 | Często (30–79%) | W 1 chorobie |
| GRIP1glutamate receptor interacting protein 1 | Często (30–79%) | W 1 chorobie |
| H4C3H4 clustered histone 3 | Często (30–79%) | W 1 chorobie |
| H4C9H4 clustered histone 9 | Często (30–79%) | W 1 chorobie |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| HBA1hemoglobin subunit alpha 1 | Często (30–79%) | W 1 chorobie |
| HBA2hemoglobin subunit alpha 2 | Często (30–79%) | W 1 chorobie |
| HID1HID1 domain containing | Często (30–79%) | W 1 chorobie |
| HNRNPUheterogeneous nuclear ribonucleoprotein U | Często (30–79%) | W 1 chorobie |
| HSD17B4hydroxysteroid 17-beta dehydrogenase 4 | Często (30–79%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Często (30–79%) | W 2 chorobach |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| IFT43intraflagellar transport 43 | Często (30–79%) | W 1 chorobie |
| INPPL1inositol polyphosphate phosphatase like 1 | Często (30–79%) | W 1 chorobie |
| INTS8integrator complex subunit 8 | Często (30–79%) | W 1 chorobie |
| IPO8importin 8 | Często (30–79%) | W 2 chorobach |
| KAT6Blysine acetyltransferase 6B | Często (30–79%) | W 1 chorobie |
| KIF21Akinesin family member 21A | Często (30–79%) | W 1 chorobie |
| KLHL20kelch like family member 20 | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 2 chorobach |
| KNSTRNkinetochore localized astrin (SPAG5) binding protein | Często (30–79%) | W 2 chorobach |
| LRP4LDL receptor related protein 4 | Często (30–79%) | W 3 chorobach |
| MAFMAF bZIP transcription factor | Często (30–79%) | W 2 chorobach |
| MAGEL2MAGE family member L2 | Często (30–79%) | W 1 chorobie |
| MAN1B1mannosidase alpha class 1B member 1 | Często (30–79%) | W 2 chorobach |
| MAN2B1mannosidase alpha class 2B member 1 | Często (30–79%) | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Często (30–79%) | W 3 chorobach |
| MAPK1mitogen-activated protein kinase 1 | Często (30–79%) | W 1 chorobie |
| MARS2methionyl-tRNA synthetase 2, mitochondrial | Często (30–79%) | W 1 chorobie |
| MASP1MBL associated serine protease 1 | Często (30–79%) | W 2 chorobach |
| MBD5methyl-CpG binding domain protein 5 | Często (30–79%) | W 1 chorobie |
| MCTP2multiple C2 and transmembrane domain containing 2 | Często (30–79%) | W 1 chorobie |
| MED12mediator complex subunit 12 | Często (30–79%) | W 3 chorobach |
| MED25mediator complex subunit 25 | Często (30–79%) | W 2 chorobach |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 4 chorobach |
| MUSKmuscle associated receptor tyrosine kinase | Często (30–79%) | W 2 chorobach |
| MYOD1myogenic differentiation 1 | Często (30–79%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Często (30–79%) | W 1 chorobie |
| NCDNneurochondrin | Często (30–79%) | W 1 chorobie |
| NFIXnuclear factor I X | Często (30–79%) | W 1 chorobie |
| NGLY1N-glycanase 1 | Często (30–79%) | W 1 chorobie |
| NKX2-5NK2 homeobox 5 | Często (30–79%) | W 2 chorobach |
| NOTCH3notch receptor 3 | Często (30–79%) | W 3 chorobach |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Często (30–79%) | W 1 chorobie |
| NUP88nucleoporin 88 | Często (30–79%) | W 1 chorobie |
| OTUD5OTU deubiquitinase 5 | Często (30–79%) | W 1 chorobie |
| PACS1phosphofurin acidic cluster sorting protein 1 | Często (30–79%) | W 2 chorobach |
| PACS2phosphofurin acidic cluster sorting protein 2 | Często (30–79%) | W 1 chorobie |
| PAICSphosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase | Często (30–79%) | W 1 chorobie |
| PAN2poly(A) specific ribonuclease subunit PAN2 | Często (30–79%) | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Często (30–79%) | W 2 chorobach |
| PDE6Dphosphodiesterase 6D | Często (30–79%) | W 1 chorobie |
| PHACTR1phosphatase and actin regulator 1 | Często (30–79%) | W 1 chorobie |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Często (30–79%) | W 2 chorobach |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Często (30–79%) | W 3 chorobach |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Często (30–79%) | W 3 chorobach |
| PIK3R2phosphoinositide-3-kinase regulatory subunit 2 | Często (30–79%) | W 1 chorobie |
| PITX1paired like homeodomain 1 | Często (30–79%) | W 1 chorobie |
| PMM2phosphomannomutase 2 | Często (30–79%) | W 1 chorobie |
| POLR2ARNA polymerase II subunit A | Często (30–79%) | W 1 chorobie |
| PORcytochrome p450 oxidoreductase | Często (30–79%) | W 1 chorobie |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Często (30–79%) | W 2 chorobach |
| PPP1R21protein phosphatase 1 regulatory subunit 21 | Często (30–79%) | W 1 chorobie |
| PPP2R1Aprotein phosphatase 2 scaffold subunit Aalpha | Często (30–79%) | W 2 chorobach |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Często (30–79%) | W 2 chorobach |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 2 chorobach |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Często (30–79%) | W 1 chorobie |
| PSAT1phosphoserine aminotransferase 1 | Często (30–79%) | W 2 chorobach |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 2 chorobach |
| PTENphosphatase and tensin homolog | Często (30–79%) | W 2 chorobach |
| PUS1pseudouridine synthase 1 | Często (30–79%) | W 1 chorobie |
| QRICH1glutamine rich 1 | Często (30–79%) | W 1 chorobie |
| RAB34RAB34, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RAD21RAD21 cohesin complex component | Często (30–79%) | W 1 chorobie |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 3 chorobach |
| RBL2RB transcriptional corepressor like 2 | Często (30–79%) | W 1 chorobie |
| RBM10RNA binding motif protein 10 | Często (30–79%) | W 2 chorobach |
| RLIMring finger protein, LIM domain interacting | Często (30–79%) | W 1 chorobie |
| RNU4ATACRNA, U4atac small nuclear | Często (30–79%) | W 1 chorobie |
| RPGRIP1RPGR interacting protein 1 | Często (30–79%) | W 1 chorobie |
| RPGRIP1LRPGRIP1 like | Często (30–79%) | W 1 chorobie |
| RUSC2RUN and SH3 domain containing 2 | Często (30–79%) | W 1 chorobie |
| SCNM1sodium channel modifier 1 | Często (30–79%) | W 1 chorobie |
| SEMA5Asemaphorin 5A | Często (30–79%) | W 1 chorobie |
| SETSET nuclear proto-oncogene | Często (30–79%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Często (30–79%) | W 3 chorobach |
| SETD1ASET domain containing 1A, histone lysine methyltransferase | Często (30–79%) | W 1 chorobie |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Często (30–79%) | W 2 chorobach |
| SIX2SIX homeobox 2 | Często (30–79%) | W 1 chorobie |
| SKIC2SKI2 subunit of superkiller complex | Często (30–79%) | W 2 chorobach |
| SLC12A6solute carrier family 12 member 6 | Często (30–79%) | W 1 chorobie |
| SLC18A3solute carrier family 18 member A3 | Często (30–79%) | W 1 chorobie |
| SLC25A12solute carrier family 25 member 12 | Często (30–79%) | W 1 chorobie |
| SLC26A2solute carrier family 26 member 2 | Często (30–79%) | W 2 chorobach |
| SLC2A10solute carrier family 2 member 10 | Często (30–79%) | W 2 chorobach |
| SMAD2SMAD family member 2 | Często (30–79%) | W 3 chorobach |
| SMAD3SMAD family member 3 | Często (30–79%) | W 4 chorobach |
| SMARCA2SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 | Często (30–79%) | W 1 chorobie |
| SMG9SMG9 nonsense mediated mRNA decay factor | Często (30–79%) | W 1 chorobie |
| SPARTspartin | Często (30–79%) | W 2 chorobach |
| SUPT16HSPT16 homolog, facilitates chromatin remodeling subunit | Często (30–79%) | W 2 chorobach |
| TAF1TATA-box binding protein associated factor 1 | Często (30–79%) | W 1 chorobie |
| TBC1D24TBC1 domain family member 24 | Często (30–79%) | W 2 chorobach |
| TBCEtubulin folding cofactor E | Często (30–79%) | W 2 chorobach |
| TBCKTBC1 domain containing kinase | Często (30–79%) | W 1 chorobie |
| TBL1XR1TBL1X/Y related 1 | Często (30–79%) | W 2 chorobach |
| TBR1T-box brain transcription factor 1 | Często (30–79%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Często (30–79%) | W 4 chorobach |
| TBX2T-box transcription factor 2 | Często (30–79%) | W 1 chorobie |
| TCTN1tectonic family member 1 | Często (30–79%) | W 1 chorobie |
| TCTN2tectonic family member 2 | Często (30–79%) | W 1 chorobie |
| TGDSTDP-glucose 4,6-dehydratase | Często (30–79%) | W 2 chorobach |
| TGFB2transforming growth factor beta 2 | Często (30–79%) | W 3 chorobach |
| TGFB3transforming growth factor beta 3 | Często (30–79%) | W 3 chorobach |
| THSD1thrombospondin type 1 domain containing 1 | Często (30–79%) | W 1 chorobie |
| TLK2tousled like kinase 2 | Często (30–79%) | W 1 chorobie |
| TMEM107transmembrane protein 107 | Często (30–79%) | W 1 chorobie |
| TMEM216transmembrane protein 216 | Często (30–79%) | W 3 chorobach |
| TMEM231transmembrane protein 231 | Często (30–79%) | W 2 chorobach |
| TMEM237transmembrane protein 237 | Często (30–79%) | W 2 chorobach |
| TMEM67transmembrane protein 67 | Często (30–79%) | W 2 chorobach |
| TOGARAM1TOG array regulator of axonemal microtubules 1 | Często (30–79%) | W 1 chorobie |
| TOPORSTOP1 binding arginine/serine rich protein, E3 ubiquitin ligase | Często (30–79%) | W 1 chorobie |
| TRAF7TNF receptor associated factor 7 | Często (30–79%) | W 1 chorobie |
| TRIM33tripartite motif containing 33 | Często (30–79%) | W 1 chorobie |
| TRIP4thyroid hormone receptor interactor 4 | Często (30–79%) | W 1 chorobie |
| TUBA1Atubulin alpha 1a | Często (30–79%) | W 1 chorobie |
| TUBBtubulin beta class I | Często (30–79%) | W 1 chorobie |
| TXNDC15thioredoxin domain containing 15 | Często (30–79%) | W 2 chorobach |
| UBE2Aubiquitin conjugating enzyme E2 A | Często (30–79%) | W 2 chorobach |
| UBE3Bubiquitin protein ligase E3B | Często (30–79%) | W 1 chorobie |
| UBR7ubiquitin protein ligase E3 component n-recognin 7 | Często (30–79%) | W 1 chorobie |
| UMPSuridine monophosphate synthetase | Często (30–79%) | W 1 chorobie |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Często (30–79%) | W 1 chorobie |
| VAC14VAC14 component of PIKFYVE complex | Często (30–79%) | W 1 chorobie |
| VSX1visual system homeobox 1 | Często (30–79%) | W 1 chorobie |
| WBP4WW domain binding protein 4 | Często (30–79%) | W 1 chorobie |
| WDR26WD repeat domain 26 | Często (30–79%) | W 1 chorobie |
| WDR37WD repeat domain 37 | Często (30–79%) | W 1 chorobie |
| ZNF292zinc finger protein 292 | Często (30–79%) | W 1 chorobie |
| AARS1alanyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| ACTA1actin alpha 1, skeletal muscle | Czasami (5–29%) | W 2 chorobach |
| ACTA2actin alpha 2, smooth muscle | Czasami (5–29%) | W 1 chorobie |
| ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15 | Czasami (5–29%) | W 1 chorobie |
| ADAMTSL2ADAMTS like 2 | Czasami (5–29%) | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Czasami (5–29%) | W 1 chorobie |
| ADGRG6adhesion G protein-coupled receptor G6 | Czasami (5–29%) | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Czasami (5–29%) | W 1 chorobie |
| AFF3ALF transcription elongation factor 3 | Czasami (5–29%) | W 1 chorobie |
| ALG6ALG6 alpha-1,3-glucosyltransferase | Czasami (5–29%) | W 1 chorobie |
| ANK1ankyrin 1 | Czasami (5–29%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| ASXL3ASXL transcriptional regulator 3 | Czasami (5–29%) | W 2 chorobach |
| B4GALT1beta-1,4-galactosyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Czasami (5–29%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Czasami (5–29%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Czasami (5–29%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Czasami (5–29%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Czasami (5–29%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Czasami (5–29%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Czasami (5–29%) | W 1 chorobie |
| BCAS3BCAS3 microtubule associated cell migration factor | Czasami (5–29%) | W 1 chorobie |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Czasami (5–29%) | W 1 chorobie |
| BLNKB cell linker | Czasami (5–29%) | W 1 chorobie |
| BRCA1BRCA1 DNA repair associated | Czasami (5–29%) | W 2 chorobach |
| BRCA2BRCA2 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRIP1BRCA1 interacting DNA helicase 1 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Czasami (5–29%) | W 1 chorobie |
| CAPRIN1cell cycle associated protein 1 | Czasami (5–29%) | W 1 chorobie |
| CARS1cysteinyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| CD79ACD79a molecule | Czasami (5–29%) | W 1 chorobie |
| CD79BCD79b molecule | Czasami (5–29%) | W 1 chorobie |
| CDC42cell division cycle 42 | Czasami (5–29%) | W 2 chorobach |
| CDC42BPBCDC42 binding protein kinase beta | Czasami (5–29%) | W 1 chorobie |
| CDCA7cell division cycle associated 7 | Czasami (5–29%) | W 2 chorobach |
| CDH2cadherin 2 | Czasami (5–29%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Czasami (5–29%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Czasami (5–29%) | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Czasami (5–29%) | W 3 chorobach |
| CHRNA7cholinergic receptor nicotinic alpha 7 subunit | Czasami (5–29%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Czasami (5–29%) | W 1 chorobie |
| CNOT3CCR4-NOT transcription complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Czasami (5–29%) | W 2 chorobach |
| COG3component of oligomeric golgi complex 3 | Czasami (5–29%) | W 1 chorobie |
| COG8component of oligomeric golgi complex 8 | Czasami (5–29%) | W 1 chorobie |
| COL11A2collagen type XI alpha 2 chain | Czasami (5–29%) | W 1 chorobie |
| COL25A1collagen type XXV alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CSNK2A1casein kinase 2 alpha 1 | Czasami (5–29%) | W 1 chorobie |
| CTCFCCCTC-binding factor | Czasami (5–29%) | W 2 chorobach |
| DBR1debranching RNA lariats 1 | Czasami (5–29%) | W 2 chorobach |
| DCHS1dachsous cadherin-related 1 | Czasami (5–29%) | W 2 chorobach |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Czasami (5–29%) | W 1 chorobie |
| DHX37DEAH-box helicase 37 | Czasami (5–29%) | W 1 chorobie |
| DNMT3BDNA methyltransferase 3 beta | Czasami (5–29%) | W 2 chorobach |
| DPF2double PHD fingers 2 | Czasami (5–29%) | W 1 chorobie |
| DPH2diphthamide biosynthesis 2 | Czasami (5–29%) | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| DUSP6dual specificity phosphatase 6 | Czasami (5–29%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Czasami (5–29%) | W 1 chorobie |
| EDEM3ER degradation enhancing alpha-mannosidase like protein 3 | Czasami (5–29%) | W 1 chorobie |
| EIF5Aeukaryotic translation initiation factor 5A | Czasami (5–29%) | W 1 chorobie |
| ELNelastin | Czasami (5–29%) | W 1 chorobie |
| EMC1ER membrane protein complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| EMX2empty spiracles homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| EPG5ectopic P-granules 5 autophagy tethering factor | Czasami (5–29%) | W 2 chorobach |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Czasami (5–29%) | W 1 chorobie |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Czasami (5–29%) | W 1 chorobie |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| ERGIC1endoplasmic reticulum-golgi intermediate compartment 1 | Czasami (5–29%) | W 1 chorobie |
| EXTL3exostosin like glycosyltransferase 3 | Czasami (5–29%) | W 1 chorobie |
| FANCAFA complementation group A | Czasami (5–29%) | W 1 chorobie |
| FANCBFA complementation group B | Czasami (5–29%) | W 1 chorobie |
| FANCCFA complementation group C | Czasami (5–29%) | W 1 chorobie |
| FANCD2FA complementation group D2 | Czasami (5–29%) | W 2 chorobach |
| FANCEFA complementation group E | Czasami (5–29%) | W 1 chorobie |
| FANCFFA complementation group F | Czasami (5–29%) | W 1 chorobie |
| FANCGFA complementation group G | Czasami (5–29%) | W 1 chorobie |
| FANCIFA complementation group I | Czasami (5–29%) | W 1 chorobie |
| FANCMFA complementation group M | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FGF17fibroblast growth factor 17 | Czasami (5–29%) | W 1 chorobie |
| FGF3fibroblast growth factor 3 | Czasami (5–29%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Czasami (5–29%) | W 1 chorobie |
| FIBPFGF1 intracellular binding protein | Czasami (5–29%) | W 2 chorobach |
| FOXE3forkhead box E3 | Czasami (5–29%) | W 1 chorobie |
| FOXP2forkhead box P2 | Czasami (5–29%) | W 1 chorobie |
| FRA10AC1FRA10A associated CGG repeat 1 | Czasami (5–29%) | W 1 chorobie |
| FRYLFRY like transcription coactivator | Czasami (5–29%) | W 1 chorobie |
| GATA6GATA binding protein 6 | Czasami (5–29%) | W 1 chorobie |
| GATAD2BGATA zinc finger domain containing 2B | Czasami (5–29%) | W 2 chorobach |
| GINS3GINS complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| GNPNAT1glucosamine-phosphate N-acetyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Czasami (5–29%) | W 1 chorobie |
| GNRH1gonadotropin releasing hormone 1 | Czasami (5–29%) | W 1 chorobie |
| GNRHRgonadotropin releasing hormone receptor | Czasami (5–29%) | W 1 chorobie |
| GON7GON7 subunit of KEOPS complex | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GTF2E2general transcription factor IIE subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GTF2H5general transcription factor IIH subunit 5 | Czasami (5–29%) | W 1 chorobie |
| H3-3AH3.3 histone A | Czasami (5–29%) | W 1 chorobie |
| HEATR3HEAT repeat containing 3 | Czasami (5–29%) | W 2 chorobach |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Czasami (5–29%) | W 1 chorobie |
| HELLShelicase, lymphoid specific | Czasami (5–29%) | W 2 chorobach |
| HEY2hes related family bHLH transcription factor with YRPW motif 2 | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HNRNPCheterogeneous nuclear ribonucleoprotein C | Czasami (5–29%) | W 1 chorobie |
| HNRNPH2heterogeneous nuclear ribonucleoprotein H2 | Czasami (5–29%) | W 1 chorobie |
| HPDL4-hydroxyphenylpyruvate dioxygenase like | Czasami (5–29%) | W 1 chorobie |
| HS2ST1heparan sulfate 2-O-sulfotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Czasami (5–29%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Czasami (5–29%) | W 1 chorobie |
| IFT56intraflagellar transport 56 | Czasami (5–29%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Czasami (5–29%) | W 1 chorobie |
| IGHMimmunoglobulin heavy constant mu | Czasami (5–29%) | W 1 chorobie |
| IGLL1immunoglobulin lambda like polypeptide 1 | Czasami (5–29%) | W 1 chorobie |
| IL11RAinterleukin 11 receptor subunit alpha | Czasami (5–29%) | W 1 chorobie |
| INSRinsulin receptor | Czasami (5–29%) | W 1 chorobie |
| JARID2jumonji and AT-rich interaction domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| KBTBD13kelch repeat and BTB domain containing 13 | Czasami (5–29%) | W 1 chorobie |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Czasami (5–29%) | W 1 chorobie |
| KCNN3potassium calcium-activated channel subfamily N member 3 | Czasami (5–29%) | W 1 chorobie |
| KDM1Alysine demethylase 1A | Czasami (5–29%) | W 1 chorobie |
| KDM2Blysine demethylase 2B | Czasami (5–29%) | W 1 chorobie |
| KDM5Alysine demethylase 5A | Czasami (5–29%) | W 1 chorobie |
| KDM6Alysine demethylase 6A | Czasami (5–29%) | W 1 chorobie |
| KIAA0586KIAA0586 | Czasami (5–29%) | W 1 chorobie |
| KICS2KICSTOR subunit 2 | Czasami (5–29%) | W 1 chorobie |
| KIF15kinesin family member 15 | Czasami (5–29%) | W 1 chorobie |
| KIFBPkinesin family binding protein | Czasami (5–29%) | W 1 chorobie |
| KISS1KiSS-1 metastasis suppressor | Czasami (5–29%) | W 1 chorobie |
| KISS1RKISS1 receptor | Czasami (5–29%) | W 1 chorobie |
| KLF13KLF transcription factor 13 | Czasami (5–29%) | W 1 chorobie |
| KLHL41kelch like family member 41 | Czasami (5–29%) | W 2 chorobach |
| KMT2Dlysine methyltransferase 2D | Czasami (5–29%) | W 2 chorobach |
| KPTNkaptin, actin binding protein | Czasami (5–29%) | W 1 chorobie |
| KREMEN1kringle containing transmembrane protein 1 | Czasami (5–29%) | W 1 chorobie |
| LAGE3L antigen family member 3 | Czasami (5–29%) | W 1 chorobie |
| LMBR1limb development membrane protein 1 | Czasami (5–29%) | W 1 chorobie |
| LMNB1lamin B1 | Czasami (5–29%) | W 1 chorobie |
| LOXlysyl oxidase | Czasami (5–29%) | W 1 chorobie |
| LRRC7leucine rich repeat containing 7 | Czasami (5–29%) | W 1 chorobie |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Czasami (5–29%) | W 2 chorobach |
| LTBP3latent transforming growth factor beta binding protein 3 | Czasami (5–29%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Czasami (5–29%) | W 1 chorobie |
| MACF1microtubule actin crosslinking factor 1 | Czasami (5–29%) | W 1 chorobie |
| MAD2L2mitotic arrest deficient 2 like 2 | Czasami (5–29%) | W 1 chorobie |
| MAN2C1mannosidase alpha class 2C member 1 | Czasami (5–29%) | W 1 chorobie |
| MAPRE2microtubule associated protein RP/EB family member 2 | Czasami (5–29%) | W 1 chorobie |
| MARK2microtubule affinity regulating kinase 2 | Czasami (5–29%) | W 1 chorobie |
| MAT2Amethionine adenosyltransferase 2A | Czasami (5–29%) | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Czasami (5–29%) | W 1 chorobie |
| MED12Lmediator complex subunit 12L | Czasami (5–29%) | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Czasami (5–29%) | W 2 chorobach |
| MED27mediator complex subunit 27 | Czasami (5–29%) | W 1 chorobie |
| MFAP5microfibril associated protein 5 | Czasami (5–29%) | W 1 chorobie |
| MGAT2alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Czasami (5–29%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Czasami (5–29%) | W 1 chorobie |
| MPLKIPM-phase specific PLK1 interacting protein | Czasami (5–29%) | W 1 chorobie |
| MYH11myosin heavy chain 11 | Czasami (5–29%) | W 1 chorobie |
| MYLKmyosin light chain kinase | Czasami (5–29%) | W 1 chorobie |
| MYPNmyopalladin | Czasami (5–29%) | W 1 chorobie |
| NARS1asparaginyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| NAV3neuron navigator 3 | Czasami (5–29%) | W 1 chorobie |
| NBASNBAS subunit of NRZ tethering complex | Czasami (5–29%) | W 1 chorobie |
| NEBnebulin | Czasami (5–29%) | W 3 chorobach |
| NEDD4LNEDD4 like E3 ubiquitin protein ligase | Czasami (5–29%) | W 1 chorobie |
| NHLH2nescient helix-loop-helix 2 | Czasami (5–29%) | W 1 chorobie |
| NKX2-6NK2 homeobox 6 | Czasami (5–29%) | W 1 chorobie |
| NONOnon-POU domain containing octamer binding | Czasami (5–29%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Czasami (5–29%) | W 1 chorobie |
| NRCAMneuronal cell adhesion molecule | Czasami (5–29%) | W 1 chorobie |
| NSMCE3NSE3 component of SMC5/6 complex | Czasami (5–29%) | W 1 chorobie |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Czasami (5–29%) | W 1 chorobie |
| NSRP1nuclear speckle splicing regulatory protein 1 | Czasami (5–29%) | W 1 chorobie |
| NSUN2NOP2/Sun RNA methyltransferase 2 | Czasami (5–29%) | W 1 chorobie |
| NUP107nucleoporin 107 | Czasami (5–29%) | W 1 chorobie |
| NUP133nucleoporin 133 | Czasami (5–29%) | W 1 chorobie |
| OSGEPO-sialoglycoprotein endopeptidase | Czasami (5–29%) | W 2 chorobach |
| PDGFRBplatelet derived growth factor receptor beta | Czasami (5–29%) | W 1 chorobie |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Czasami (5–29%) | W 2 chorobach |
| PITX2paired like homeodomain 2 | Czasami (5–29%) | W 1 chorobie |
| PLP1proteolipid protein 1 | Czasami (5–29%) | W 1 chorobie |
| POLR1BRNA polymerase I subunit B | Czasami (5–29%) | W 1 chorobie |
| POLR1CRNA polymerase I and III subunit C | Czasami (5–29%) | W 1 chorobie |
| POLR1DRNA polymerase I and III subunit D | Czasami (5–29%) | W 1 chorobie |
| PPP1R12Aprotein phosphatase 1 regulatory subunit 12A | Czasami (5–29%) | W 1 chorobie |
| PPP2CAprotein phosphatase 2 catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Czasami (5–29%) | W 1 chorobie |
| PRDM13PR/SET domain 13 | Czasami (5–29%) | W 1 chorobie |
| PRDM5PR/SET domain 5 | Czasami (5–29%) | W 1 chorobie |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Czasami (5–29%) | W 1 chorobie |
| PRKG1protein kinase cGMP-dependent 1 | Czasami (5–29%) | W 1 chorobie |
| PROK2prokineticin 2 | Czasami (5–29%) | W 1 chorobie |
| PROKR2prokineticin receptor 2 | Czasami (5–29%) | W 1 chorobie |
| PRORPprotein only RNase P catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| PTCH1patched 1 | Czasami (5–29%) | W 3 chorobach |
| PTCH2patched 2 | Czasami (5–29%) | W 1 chorobie |
| PTPMT1protein tyrosine phosphatase mitochondrial 1 | Czasami (5–29%) | W 1 chorobie |
| PYCR2pyrroline-5-carboxylate reductase 2 | Czasami (5–29%) | W 1 chorobie |
| RAD51RAD51 recombinase | Czasami (5–29%) | W 1 chorobie |
| RAD51CRAD51 paralog C | Czasami (5–29%) | W 1 chorobie |
| RAP1BRAP1B, member of RAS oncogene family | Czasami (5–29%) | W 1 chorobie |
| REREarginine-glutamic acid dipeptide repeats | Czasami (5–29%) | W 1 chorobie |
| RFWD3ring finger and WD repeat domain 3 | Czasami (5–29%) | W 1 chorobie |
| RNF113Aring finger protein 113A | Czasami (5–29%) | W 1 chorobie |
| RPS19ribosomal protein S19 | Czasami (5–29%) | W 2 chorobach |
| RRAGCRas related GTP binding C | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RSPO2R-spondin 2 | Czasami (5–29%) | W 1 chorobie |
| SALL4spalt like transcription factor 4 | Czasami (5–29%) | W 2 chorobach |
| SCAPERS-phase cyclin A associated protein in the ER | Czasami (5–29%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Czasami (5–29%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Czasami (5–29%) | W 1 chorobie |
| SCYL2SCY1 like pseudokinase 2 | Czasami (5–29%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SEMA3Esemaphorin 3E | Czasami (5–29%) | W 1 chorobie |
| SGSM3small G protein signaling modulator 3 | Czasami (5–29%) | W 1 chorobie |
| SH2B1SH2B adaptor protein 1 | Czasami (5–29%) | W 1 chorobie |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Czasami (5–29%) | W 1 chorobie |
| SLC1A4solute carrier family 1 member 4 | Czasami (5–29%) | W 1 chorobie |
| SLC32A1solute carrier family 32 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC35C1solute carrier family 35 member C1 | Czasami (5–29%) | W 1 chorobie |
| SLX4SLX4 structure-specific endonuclease subunit | Czasami (5–29%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Czasami (5–29%) | W 2 chorobach |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Czasami (5–29%) | W 1 chorobie |
| SMSspermine synthase | Czasami (5–29%) | W 2 chorobach |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Czasami (5–29%) | W 1 chorobie |
| SOX6SRY-box transcription factor 6 | Czasami (5–29%) | W 1 chorobie |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| SPI1Spi-1 proto-oncogene | Czasami (5–29%) | W 1 chorobie |
| SPINT2serine peptidase inhibitor, Kunitz type 2 | Czasami (5–29%) | W 1 chorobie |
| SPRY4sprouty RTK signaling antagonist 4 | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| TAC3tachykinin precursor 3 | Czasami (5–29%) | W 1 chorobie |
| TACR3tachykinin receptor 3 | Czasami (5–29%) | W 1 chorobie |
| TAOK1TAO kinase 1 | Czasami (5–29%) | W 1 chorobie |
| TARS1threonyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| TBCBtubulin folding cofactor B | Czasami (5–29%) | W 1 chorobie |
| TBCDtubulin folding cofactor D | Czasami (5–29%) | W 2 chorobach |
| TBX4T-box transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| TCF12transcription factor 12 | Czasami (5–29%) | W 1 chorobie |
| TCOF1treacle ribosome biogenesis factor 1 | Czasami (5–29%) | W 1 chorobie |
| TELO2telomere maintenance 2 | Czasami (5–29%) | W 1 chorobie |
| THOC2THO complex subunit 2 | Czasami (5–29%) | W 1 chorobie |
| THSD4thrombospondin type 1 domain containing 4 | Czasami (5–29%) | W 2 chorobach |
| TMEM138transmembrane protein 138 | Czasami (5–29%) | W 1 chorobie |
| TMEM147transmembrane protein 147 | Czasami (5–29%) | W 1 chorobie |
| TP53RKTP53 regulating kinase | Czasami (5–29%) | W 2 chorobach |
| TPM2tropomyosin 2 | Czasami (5–29%) | W 1 chorobie |
| TPM3tropomyosin 3 | Czasami (5–29%) | W 2 chorobach |
| TRIM32tripartite motif containing 32 | Czasami (5–29%) | W 1 chorobie |
| TRIOtrio Rho guanine nucleotide exchange factor | Czasami (5–29%) | W 2 chorobach |
| TRIP12thyroid hormone receptor interactor 12 | Czasami (5–29%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Czasami (5–29%) | W 1 chorobie |
| UBE2Tubiquitin conjugating enzyme E2 T | Czasami (5–29%) | W 1 chorobie |
| UFC1ubiquitin-fold modifier conjugating enzyme 1 | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| UHRF1ubiquitin like with PHD and ring finger domains 1 | Czasami (5–29%) | W 1 chorobie |
| WACWW domain containing adaptor with coiled-coil | Czasami (5–29%) | W 2 chorobach |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Czasami (5–29%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Czasami (5–29%) | W 1 chorobie |
| WDR4WDR4 tRNA N7-guanosine methyltransferase non-catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| WDR73WD repeat domain 73 | Czasami (5–29%) | W 2 chorobach |
| WDR83OSWD repeat domain 83 opposite strand | Czasami (5–29%) | W 1 chorobie |
| WSB2WD repeat and SOCS box containing 2 | Czasami (5–29%) | W 1 chorobie |
| XRCC2X-ray repair cross complementing 2 | Czasami (5–29%) | W 1 chorobie |
| YRDCyrdC N6-threonylcarbamoyltransferase domain containing | Czasami (5–29%) | W 1 chorobie |
| ZBTB24zinc finger and BTB domain containing 24 | Czasami (5–29%) | W 2 chorobach |
| ZEB2zinc finger E-box binding homeobox 2 | Czasami (5–29%) | W 3 chorobach |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZIC1Zic family zinc finger 1 | Czasami (5–29%) | W 2 chorobach |
| ZMYM2zinc finger MYM-type containing 2 | Czasami (5–29%) | W 1 chorobie |
| ZMYND11zinc finger MYND-type containing 11 | Czasami (5–29%) | W 1 chorobie |
| ZNF462zinc finger protein 462 | Czasami (5–29%) | W 1 chorobie |
| ZNF469zinc finger protein 469 | Czasami (5–29%) | W 1 chorobie |
| ZNF526zinc finger protein 526 | Czasami (5–29%) | W 1 chorobie |
| ZNF699zinc finger protein 699 | Czasami (5–29%) | W 1 chorobie |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Czasami (5–29%) | W 1 chorobie |
| ACY1aminoacylase 1 | Rzadko (1–4%) | W 2 chorobach |
| ADA2adenosine deaminase 2 | Rzadko (1–4%) | W 1 chorobie |
| ALDH3A2aldehyde dehydrogenase 3 family member A2 | Rzadko (1–4%) | W 1 chorobie |
| FOXF1forkhead box F1 | Rzadko (1–4%) | W 1 chorobie |
| GATA1GATA binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Rzadko (1–4%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Rzadko (1–4%) | W 1 chorobie |
| HEPACAMhepatic and glial cell adhesion molecule | Rzadko (1–4%) | W 1 chorobie |
| RNU4-2RNA, U4 small nuclear 2 | Rzadko (1–4%) | W 1 chorobie |
| RPL11ribosomal protein L11 | Rzadko (1–4%) | W 1 chorobie |
| RPL15ribosomal protein L15 | Rzadko (1–4%) | W 1 chorobie |
| RPL18ribosomal protein L18 | Rzadko (1–4%) | W 1 chorobie |
| RPL26ribosomal protein L26 | Rzadko (1–4%) | W 1 chorobie |
| RPL27ribosomal protein L27 | Rzadko (1–4%) | W 1 chorobie |
| RPL31ribosomal protein L31 | Rzadko (1–4%) | W 1 chorobie |
| RPL35ribosomal protein L35 | Rzadko (1–4%) | W 1 chorobie |
| RPL35Aribosomal protein L35a | Rzadko (1–4%) | W 2 chorobach |
| RPL5ribosomal protein L5 | Rzadko (1–4%) | W 2 chorobach |
| RPL8ribosomal protein L8 | Rzadko (1–4%) | W 1 chorobie |
| RPL9ribosomal protein L9 | Rzadko (1–4%) | W 1 chorobie |
| RPS10ribosomal protein S10 | Rzadko (1–4%) | W 1 chorobie |
| RPS15Aribosomal protein S15a | Rzadko (1–4%) | W 1 chorobie |
| RPS17ribosomal protein S17 | Rzadko (1–4%) | W 1 chorobie |
| RPS20ribosomal protein S20 | Rzadko (1–4%) | W 1 chorobie |
| RPS24ribosomal protein S24 | Rzadko (1–4%) | W 1 chorobie |
| RPS26ribosomal protein S26 | Rzadko (1–4%) | W 1 chorobie |
| RPS27ribosomal protein S27 | Rzadko (1–4%) | W 1 chorobie |
| RPS28ribosomal protein S28 | Rzadko (1–4%) | W 1 chorobie |
| RPS29ribosomal protein S29 | Rzadko (1–4%) | W 1 chorobie |
| RPS7ribosomal protein S7 | Rzadko (1–4%) | W 2 chorobach |
| TSR2TSR2 ribosome maturation factor | Rzadko (1–4%) | W 1 chorobie |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Nie odnotowano | W 1 chorobie |
| AMER1APC membrane recruitment protein 1 | Nie odnotowano | W 1 chorobie |
| AP4S1adaptor related protein complex 4 subunit sigma 1 | Nie odnotowano | W 1 chorobie |
| AVParginine vasopressin | Nie odnotowano | W 1 chorobie |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Nie odnotowano | W 1 chorobie |
| BLTP1bridge-like lipid transfer protein family member 1 | Nie odnotowano | W 1 chorobie |
| BMPERBMP binding endothelial regulator | Nie odnotowano | W 1 chorobie |
| BUB1BBUB1 mitotic checkpoint serine/threonine kinase B | Nie odnotowano | W 1 chorobie |
| C12orf57chromosome 12 open reading frame 57 | Nie odnotowano | W 1 chorobie |
| CDK10cyclin dependent kinase 10 | Nie odnotowano | W 1 chorobie |
| CENPFcentromere protein F | Nie odnotowano | W 1 chorobie |
| CHD4chromodomain helicase DNA binding protein 4 | Nie odnotowano | W 1 chorobie |
| CHRNA1cholinergic receptor nicotinic alpha 1 subunit | Nie odnotowano | W 1 chorobie |
| CHRNDcholinergic receptor nicotinic delta subunit | Nie odnotowano | W 1 chorobie |
| CHSY1chondroitin sulfate synthase 1 | Nie odnotowano | W 1 chorobie |
| CITcitron rho-interacting serine/threonine kinase | Nie odnotowano | W 1 chorobie |
| CNTN1contactin 1 | Nie odnotowano | W 1 chorobie |
| COL27A1collagen type XXVII alpha 1 chain | Nie odnotowano | W 1 chorobie |
| CTU2cytosolic thiouridylase subunit 2 | Nie odnotowano | W 1 chorobie |
| DDX3XDEAD-box helicase 3 X-linked | Nie odnotowano | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Nie odnotowano | W 1 chorobie |
| DOCK6dedicator of cytokinesis 6 | Nie odnotowano | W 1 chorobie |
| EIF2AK3eukaryotic translation initiation factor 2 alpha kinase 3 | Nie odnotowano | W 1 chorobie |
| EXOSC9exosome component 9 | Nie odnotowano | W 1 chorobie |
| FAM20CFAM20C golgi associated secretory pathway kinase | Nie odnotowano | W 1 chorobie |
| FLCNfolliculin | Nie odnotowano | W 1 chorobie |
| GALNT2polypeptide N-acetylgalactosaminyltransferase 2 | Nie odnotowano | W 1 chorobie |
| GBA1glucosylceramidase beta 1 | Nie odnotowano | W 1 chorobie |
| GKglycerol kinase | Nie odnotowano | W 1 chorobie |
| GLB1galactosidase beta 1 | Nie odnotowano | W 1 chorobie |
| HDAC8histone deacetylase 8 | Nie odnotowano | W 1 chorobie |
| HRASHRas proto-oncogene, GTPase | Nie odnotowano | W 2 chorobach |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Nie odnotowano | W 1 chorobie |
| INTUinturned planar cell polarity protein | Nie odnotowano | W 1 chorobie |
| ITGA3integrin subunit alpha 3 | Nie odnotowano | W 1 chorobie |
| KATNIPkatanin interacting protein | Nie odnotowano | W 1 chorobie |
| KNL1kinetochore scaffold 1 | Nie odnotowano | W 1 chorobie |
| LRPPRCleucine rich pentatricopeptide repeat containing | Nie odnotowano | W 1 chorobie |
| MED13mediator complex subunit 13 | Nie odnotowano | W 1 chorobie |
| MEF2Cmyocyte enhancer factor 2C | Nie odnotowano | W 1 chorobie |
| MMP2matrix metallopeptidase 2 | Nie odnotowano | W 1 chorobie |
| MOCS1molybdenum cofactor synthesis 1 | Nie odnotowano | W 1 chorobie |
| MOCS2molybdenum cofactor synthesis 2 | Nie odnotowano | W 1 chorobie |
| NEK1NIMA related kinase 1 | Nie odnotowano | W 1 chorobie |
| NKX3-2NK3 homeobox 2 | Nie odnotowano | W 1 chorobie |
| PARS2prolyl-tRNA synthetase 2, mitochondrial | Nie odnotowano | W 1 chorobie |
| PDHXpyruvate dehydrogenase complex component X | Nie odnotowano | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Nie odnotowano | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Nie odnotowano | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Nie odnotowano | W 1 chorobie |
| PHGDHphosphoglycerate dehydrogenase | Nie odnotowano | W 1 chorobie |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Nie odnotowano | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Nie odnotowano | W 1 chorobie |
| PPP2R5Dprotein phosphatase 2 regulatory subunit B'delta | Nie odnotowano | W 1 chorobie |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Nie odnotowano | W 1 chorobie |
| RSRC1arginine and serine rich coiled-coil 1 | Nie odnotowano | W 1 chorobie |
| SEC24DSEC24 homolog D, COPII component | Nie odnotowano | W 1 chorobie |
| SLC45A1solute carrier family 45 member 1 | Nie odnotowano | W 1 chorobie |
| SMCHD1structural maintenance of chromosomes flexible hinge domain containing 1 | Nie odnotowano | W 1 chorobie |
| SOSTsclerostin | Nie odnotowano | W 2 chorobach |
| SPRED1sprouty related EVH1 domain containing 1 | Nie odnotowano | W 1 chorobie |
| SRD5A3steroid 5 alpha-reductase 3 | Nie odnotowano | W 1 chorobie |
| STAMBPSTAM binding protein | Nie odnotowano | W 1 chorobie |
| STAT3signal transducer and activator of transcription 3 | Nie odnotowano | W 1 chorobie |
| TAPT1transmembrane anterior posterior transformation 1 | Nie odnotowano | W 1 chorobie |
| TDO2tryptophan 2,3-dioxygenase | Nie odnotowano | W 1 chorobie |
| TENM3teneurin transmembrane protein 3 | Nie odnotowano | W 1 chorobie |
| TFAP2Atranscription factor AP-2 alpha | Nie odnotowano | W 1 chorobie |
| THRAthyroid hormone receptor alpha | Nie odnotowano | W 1 chorobie |
| THUMPD1THUMP domain 1 NAT10 acetyltransferase adaptor | Nie odnotowano | W 1 chorobie |
| TMEM94transmembrane protein 94 | Nie odnotowano | W 1 chorobie |
| TONSLtonsoku like, DNA repair protein | Nie odnotowano | W 1 chorobie |
| TRIM37tripartite motif containing 37 | Nie odnotowano | W 1 chorobie |
| TRRAPtransformation/transcription domain associated protein | Nie odnotowano | W 1 chorobie |
| VPS51VPS51 subunit of GARP complex | Nie odnotowano | W 1 chorobie |
| WNK3WNK lysine deficient protein kinase 3 | Nie odnotowano | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Nie odnotowano | W 1 chorobie |
| ZIC3Zic family zinc finger 3 | Nie odnotowano | W 1 chorobie |
| ZMIZ1zinc finger MIZ-type containing 1 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni